Nrx pharmaceuticals investigation continued by former louisiana attorney general: kahn swick & foti, llc continues to investigate the officers and directors of nrx pharmaceuticals, inc. - nrxp

New orleans--(business wire)--former attorney general of louisiana, charles c. foti, jr., esq., a partner at the law firm of kahn swick & foti, llc (“ksf”), announces that ksf continues its investigation into nrx pharmaceuticals (nasdaqgm: nrxp) and provides the following update. in june 2021, the company announced that it filed an application with u.s. food and drug administration (“fda”) requesting emergency use authorization (“eua”) for zyesami, its investigational pre-commercial drug pr
NRXP Ratings Summary
NRXP Quant Ranking